0 Commenti
0 condivisioni
17 Views
0 Anteprima
Cerca
Scopri nuove persone e i loro amici a quattro zampe, e fai nuove amicizie
-
Effettua l'accesso per mettere mi piace, condividere e commentare!
-
Cancer Gene Therapy Market: Reimbursement Models Evolve for High-Cost Curative TreatmentsA new growth forecast report titled Cancer Gene Therapy Market Share, Size, Trends, Industry Analysis Report, By Therapy (Oncolytic Virotherapy, Gene Transfer); By End-Use (Research Institutes, Biopharma Companies); By Region; Segment Forecast, 2022 - 2030 introduced by Polaris Market Research represents conclusive data on the overall market. It majorly targets to provide a detailed analysis of...0 Commenti 0 condivisioni 117 Views 0 Anteprima
-
mTOR Inhibitor Oncology Drug Market Grows with Breakthroughs in Targeted Cancer Therapy"Executive Summary mTOR Inhibitor Oncology Drug Market Size and Share Forecast CAGR Value The global mTOR inhibitor oncology drug market size was valued at USD 2.52 billion in 2025 and is expected to reach USD 5.32 billion by 2033, at a CAGR of 9.80% during the forecast period Competitive analysis performed in this mTOR Inhibitor Oncology Drug Market...0 Commenti 0 condivisioni 12 Views 0 Anteprima
-
CAD/CAM Dental Devices Market Revenue Analysis: Growth, Share, Value, Size, and Insights"Executive Summary CAD/CAM Dental Devices Market Size and Share Across Top Segments Data Bridge Market Research analyses that the CAD/CAM Dental Devices market which was USD 2.5 Billion in 2022, is expected to reach USD 5.3 Billion by 2030, and is expected to undergo a CAGR of 13.2% during the forecast period 2023-2030. This global CAD/CAM Dental Devices Market report...0 Commenti 0 condivisioni 7K Views 0 Anteprima
-
Carfilzomib Market Expands with 7.5% CAGR Driven by Advances in Multiple Myeloma TherapiesAccording to a new report from Intel Market Research, the global Carfilzomib market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.89 billion by 2034, growing at a steady CAGR of 7.5% during the forecast period (2025–2034). This growth reflects the expanding clinical application of Carfilzomib in treating relapsed/refractory multiple myeloma, coupled with rising...0 Commenti 0 condivisioni 13 Views 0 Anteprima
-
Cervical Cancer Treatment Market Outlook 2025–2033: Growth, Trends & ForecastMarket Overview The global cervical cancer treatment market size was valued at USD 8.47 billion in 2024 and is expected to grow from USD 8.88 billion in 2025 to USD 12.91 billion by 2033, growing at a CAGR of 4.8% during the forecast period (2025-2033). The global Cervical Cancer Treatment market continues to evolve rapidly, driven by shifting...0 Commenti 0 condivisioni 650 Views 0 Anteprima
-
Linear Particle Accelerators Market Opportunities: Growth, Share, Value, Size, and Scope"Comprehensive Outlook on Executive Summary Linear Particle Accelerators Market Size and Share Global linear particle accelerators market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account from USD 2,346.51 million in 2020 to USD 3,672.77 million by 2028 growing at a CAGR of 5.76% in the above-mentioned...0 Commenti 0 condivisioni 2K Views 0 Anteprima
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Commenti 0 condivisioni 12 Views 0 Anteprima
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Commenti 0 condivisioni 13 Views 0 Anteprima
English
Kiswahili
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Russian
Romaian
Portuguese (Brazil)
Greek
